Compugen
CGEN2.3801.28% ( +0.030 )
Compugen (CGEN)
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and p...
- Open
- 2.340
- High
- 2.385
- Low
- 2.170
- Prev. Close
- 2.350
- Volume
- 592.85K
- Turnover
- 1.34M
- Avg Price
- 2.267
- Bid/Ask Ratio
- --
- Amplitude
- 9.15%
- 52wk High
- 3.235
- Volume Ratio
- 2.83
- Turnover Ratio
- 0.64%
Compugen Analyst Rating
View MoreForecast & Rating
Jul 21, 2026Price forecast
$4.6093.28%
Forecast & RatingStrong buy
5analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 5 hours ago
Compugen announces annual shareholder meeting
- PUBT · 10 hours ago
Compugen publishes corporate presentation on AI-driven immuno-oncology antibody pipeline
- PUBT · 10 hours ago
Compugen Q2 FY26 net loss narrows to USD 7 million; revenue more than doubled to USD 2.6 million
- StockTitan · 18 hours ago
Compugen Reports Second Quarter 2026 Results | CGEN Stock News
- MSN · 22 hours ago
Here are the major earnings before the open Monday
- PUBT · Jul 20 at 06:03 AM
Compugen to release Q2 2026 results, host conference call
